Aromatase inhibitors monotherapy (OR 2.05; 95% CI: 0.31–16.54) and tamoxifen with LHRH agonists (OR 1.25; 95% CI: 0.14–11.05) also showed a trend toward increased risk of PCIA, but these associations were not significant.
← all excerpts
Clinical and genetic predictors of persistent chemotherapy-induced alopecia despite scalp cooling in breast cancer.
1
—
—